Tell us about your organization

 
 

Tell us about you

Work Email required

Organization required

First Name required

Last Name required

Job Title required

Phone required (###) ###-####, or int ######...

City required

State/Province required

Business Information

error messages will go here...

Looks like we’re already familiar with you!

Please press next to continue with the survey.

Looks like we’re already familiar with you!

According to your account type you are not eligible to take surveys at this time. If this is a mistake, please contact KLAS.

If you are trying to access KLAS research data and reports, an email has been sent to   with a link to login.

If the email doesn't appear in your inbox, ask your IT department to add KLASresearch.com to your company spam filter's "whitelist", and check your email's spam folder.

Membership Commitment

In exchange for giving their feedback, healthcare providers can create an account to get access to industry reports, user commentary, and real-time ratings.

By submitting your account request, you are engaged in patient care as either an employee (or contractor) of your provider organization and that you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically. To learn more about how we process and protect your personal data, you may view our Privacy policy.

By submitting your account request, you confirm that you have reviewed and agree to abide by the Terms of Use for this website as updated periodically.

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

 

To learn more about how we process and protect your personal data, you may view our Privacy policy.

Thank You! Your information was submitted successfully!

Next Steps - An email has been sent to . Please follow its instructions to verify your email, and login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank You! Your information was submitted successfully!

Next Steps - A KLAS representative will contact you to discuss working with KLAS, typically within 24 to 48 hours.

If you have any further questions please contact info@klasresearch.com or 1-800-920-4109.

Surprise! Looks like we already have an account for you.

An email has been sent to blah@blah.com with a link to login.

If the email doesn't appear in your inbox, try asking your IT department to add KLASresearch.com to your company spam filter's "whitelist", and checking your email's spam folder.

Thank you !

Access info about on your dashboard or bookmark under

(Your Products / Your Organization's Products)

Imprivata

Headquarters:

Lexington Massachusetts, United States

Sector Funding:

Go to Website

Imprivata's Current COVID-19 Response and Solutions

The following information was supplied by the vendor and has not been validated by KLAS.

Confirm ID for Remote Access
Secure access for remote workforces

Many organizations are advising—and in some cases, requiring—employees to work remotely. They are providing remote network access to a greater number of users, which they are securing with Confirm ID for Remote Access, Imprivata’s enterprise multifactor authentication solution. To help healthcare organizations manage this unexpected increase in remote workers, Imprivata is offering licenses of Confirm ID for Remote Access for all users at no cost. The intention is to help organizations quickly support more remote users without compromising security.

Children’s Hospital of the King’s Daughters is one of the many Imprivata customers taking advantage of no-cost Confirm ID licenses to enable secure access for an increased remote workforce:

  • Children’s Hospital of the King’s Daughters is experiencing an increase in remote workers
  • These users need remote network access
  • Imprivata Confirm ID helps CHKD secure this remote access
  • Multifactor authentication increases security and safeguards against unauthorized access

Imprivata Confirm ID
Safely and securely prescribe controlled substances without in-person medical evaluations

Imprivata Confirm ID for EPCS helps providers and healthcare organizations comply with the specific DEA requirements for electronic prescribing for controlled substances (EPCS) while enabling a fast, secure prescribing workflow for providers. Imprivata Confirm ID offers a number of significant benefits to patients and providers, including:

  • Eliminating the need for in-person medical evaluations (for both new and refill prescriptions)—Providers can send refills for medication electronically to the patient’s pharmacy without the need for an in-person evaluation. This now applies to new prescriptions for controlled substances as well in accordance with the DEA guidance regarding telemedicine following the Department of Health and Human Services declaration of a public health emergency. By eliminating the need for an inperson medical evaluation, patients and providers can practice social distancing and reduce the risk of spreading infection.
  • Enabling remote identity proofing of providers—The DEA requires providers to complete identity proofing before they can be enabled for EPCS and authorizes institutional practitioners to conduct identity proofing in-house, but it must be done in-person. This is the method most commonly used by hospitals and health systems, but organizations now want to avoid in-person interactions wherever possible. Imprivata Confirm ID for EPCS supports this by enabling remote identity proofing through partnership with a federally approved Certification Authority. This ensures compliance with the DEA identity proofing requirement without an in-person interaction.
  • Supporting remote prescribing with phone-based two-factor authentication—The DEA requires providers to use two-factor authentication to sign EPCS orders. Many providers are now prescribing from a remote location outside the hospital. To support this, Imprivata Confirm ID supports phone-based authentication. With the simple swipe from the lock screen, providers can complete the two-factor authentication.

GroundControl
Automatically manage the provisioning and digital sanitization of shared iOS devices

GroundControl, Imprivata’s solution for automatically managing the provisioning and digital sanitization of shared iOS devices, is being used for inpatient telehealth to reduce risk of infection and save on personal protective equipment (PPE). iPads are being given to isolated patients to use in instances when communication with their care provider does not need to be in-person. Not only is this improving safety by reducing the risk of infection between patients and providers, but it goes a long way toward conserving PPE that must be discarded after each personal interaction. Imprivata has made GroundControl licenses available free of charge through July 31, 2020, to support the response to COVID-19. We hope this facilitates easier use of iPads and other mobile devices for inpatient telehealth consults, remote provider communication, virtual patient visits with loved ones, and other initiatives.

OneSign
Access logs to determine whether providers have accessed workstations in areas of the hospital that have been exposed to infection

Yale New Haven Health (YNHH) has implemented a process for using Imprivata OneSign to help mitigate the spread of infectious disease. They do this by using OneSign data to identify users who have been in areas of the hospital with a potential risk of infection.

YNHH uses multiple data points (for example, staffing sheets) as a means of assessing risk, while OneSign provides the granularity to narrow down which specific users have accessed workstations in different units. This is accomplished by analyzing the information that OneSign collects when a user taps their proximity badge to access a workstation.

That login data can be analyzed in real time via a Computer Activity and/or Login Activity report, providing a record of the user’s name, the workstation they accessed, the time and date they accessed the workstation, and how long they used it for. By matching this data to the location of the workstation, YNHH is able to determine which specific users were in areas with a risk of infection, and they can take any necessary actions.

Details on YNHH’s use case can be found at the Imprivata COVID 19 Response page. We thank Glynn Stanton, YNHH CISO, and his team for sharing this process that we hope you find valuable in your own efforts to prevent the spread of COVID 19.  

OneSign
Single sign-on capabilities that enable hospital staff to quickly access workstations, applications, and virtual desktops

Single sign-on (SSO) technology from Imprivata OneSign is enabling millions of clinicians across the world with touchless access into workstations, applications, and virtual desktops with just a tap of their badge or a swipe of a fingerprint. Providers are instantly logged into their desktops and automatically signed into their applications without needing to repeatedly type a username or password. That allows the clinicians to care for their patients, and that is what matters most during this COVID-19 outbreak. Clinicians need to focus on their patients, but the security and the privacy of patient information is also important. Imprivata OneSign makes accessing workstations simple while securing protected health information (PHI) on unattended workstations and enabling easier and more thorough auditing and reporting of workstation and application access.

Identity Governance
Manage system access for new, temporary, or newly remote staff members

Imprivata Identity Governance is being used by organizations to ramp up clinical and support staff to help manage the COVID-19 response. To handle the volume of newcomers, customers are using the “bulk feed” capability to provision access for large numbers of users. Handling multiple approvals, without impacting the provisioning process, can be challenging with mass loading. Depending on their environments, Imprivata Identity Governance customers can handle this in different ways and are able to accomplish bulk uploads quickly, maintaining their audit trails.

Imprivata Identity Governance has also been critical to grant and review remote access rights and deprovision users from remote access when it is no longer needed. Being able to promptly deprovision users from remote access capabilities has both cost and security benefits for healthcare organizations in terms of careful management of remote access licenses and assurance that systems are protected.

PatientSecure
Maintain optimal check-in throughput during times of increased case load; track patients’ interactions with staff and care providers to track potential transmission of COVID-19

During these challenging times, PatientSecure can help.

  • As volume increases and the importance of correct patient data becomes even more important, patient identification and an optimal check-in process is more important than ever
  • PatientSecure captures valuable data about when and by whom patients were checked in to the hospital or healthcare organization. This data could prove to be very important in the coming weeks/months.

For clinicians, treating patients based on their correct medical record is always important. In a pandemic situation, when healthcare providers and organizations are under intense pressure, using PatientSecure could help:

  • During times of increased caseloads, maintaining optimal check-in throughput. Whether via patient access staff or kiosks, with PatientSecure, enrolled patients don’t need to produce identity cards or other documents, and patient access staff members don’t need to identity-proof patients (and possibly handle cards) or search for records.
  • Tracking care provider/patient interaction. PatientSecure reporting captures when (date and time) and where (by facility, department, and endpoint machine) patients appear in your organization (Knowledge Article with screenshots available in the Imprivata Support and Learning Center).

Regarding managing risks related to the transmission of COVID-19, decisions about how to respond to COVID-19 patient-related contact with the PatientSecure palm vein scanners deployed at facilities ultimately rests with the infection control leadership. Having acknowledged that, below are some current suggestions for cleaning and handling:

  • PatientSecure palm vein scanners should be addressed with the same approach as for other similar equipment used at patient check-in (e.g. electronic pen pads, conventional pens, clipboards, kiosks). The CDC recommends that routine cleaning and disinfection are appropriate for reducing risk of COVID-19 transmission in healthcare settings.

The PatientSecure handguide (hand outline) and scanner housing (cup) may be cleaned with an alcohol wipe between patient uses. Per CDC guidelines, a 70% or greater alcohol solution is effective against COVID-19.


Best in KLAS Awards


Thank you !

Access info about on your dashboard or bookmark under

(Your Products / Your Organization's Products)

Software Overall Score Data collected between Jan 2020 - Jan 2021

85.7

 Product
Segment
 

Exceptions

R
Regional Classification
C
Component Products
S
Superseded Products
NP
Not Primary Products
DR
Data Review
MS
Limited Market Share
FR
Data frozen, live data no longer collected.

The following exceptions refer to the number of unique organizations contributing evaluations to the overall score (minimum of 15 required).

# of Unique Organization Evaluations:

0 - 5
L 6 - 14

Segment Position

Segment positions refer to the order in which this product is scored among competitors’ products within its market segment.

In order to be scored in a segment, the product must have sufficient data levels and be equivalent in scope to other products within that segment.

Click the segment positions listed below to learn more.